Table 1.
Patients characteristics.
| Total Patients | 124 (Mean Age 54 y; Range 31–86 y) | |
|---|---|---|
| Menopause Status | ||
| Pre | 55 (44%) | |
| Peri | 12 (10%) | |
| Post | 57 (46%) | |
| Tumor Volume (cm3)—Median (IQR) | 7.27 (3.29–13.74) | |
| Histologic Subtype | ||
| NST | 109 (88%) | |
| Lobular invasive | 7 (6%) | |
| other | 8 (6%) | |
| Molecular Subtype | ||
| Luminal A | 17 (14%) | |
| Luminal B | 82 (66%) | |
| HER2-enriched | 5 (4%) | |
| Triple negative | 19 (16%) | |
| Ki-67 | Mean: 40, range 3–97% | |
| Negative (<15%) | 13 (10%) | |
| Positive (>15%) | 111 (90%) | |
| Tumor Grade | ||
| G1 | 5 (4%) | |
| G2 | 67 (54%) | |
| G3 | 52 (42%) | |
| N-status | ||
| Positive | 49 (40%) | |
| Negative | 75 (60%) | |
| M-status | ||
| Positive | 7 (6%) | |
| Negative | 117 (94%) | |